過敏診斷市場規模、佔有率、成長分析（按產品、按檢測、按過敏原、按最終用戶、按地區）- 產業預測 2025-2032

2023 年過敏診斷市場規模價值 48 億美元，預計將從 2024 年的 53.3 億美元成長到 2032 年的 122.8 億美元，預測期內（2025-2032 年）的複合年成長率為 11.0%。

由於過敏症的日益普及、診斷技術的進步以及對檢測方法認知的不斷提高，過敏診斷市場正在經歷顯著的成長。由於環境因素和生活方式的改變，花粉症、氣喘和食物過敏等疾病的發生率不斷上升，刺激了該行業的擴張。皮膚點刺試驗和分子診斷等工具的創新將提高檢測的效率和準確性。然而，市場面臨監管障礙、先進技術高成本以及缺乏標準化等挑戰，這可能會影響患者的可靠性和可及性。儘管存在這些障礙，但由於新的診斷方法、機器學習和人工智慧的整合以及對醫療保健基礎設施的投資增加，預計市場將大幅成長。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管分析

過敏診斷市場規模（按產品和複合年成長率） (2025-2032)

• 市場概覽
• 檢測試劑套件
• 裝置
• 服務
• 耗材

過敏診斷市場規模（按測試類型和複合年成長率） (2025-2032)

• 市場概覽
• 體內測試
• 體外測試

過敏診斷市場規模（按過敏原和複合年成長率） (2025-2032)

• 市場概覽
• 吸入性過敏原
• 食物過敏原
• 藥物過敏原
• 其他過敏原

過敏診斷市場規模（按最終用戶分類）及複合年成長率（2025-2032 年）

• 市場概覽
• 診斷實驗室
• 醫院附設檢查室
• 學術研究所
• 其他最終用戶

過敏診斷市場規模（按地區分類）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Thermo Fisher Scientific Inc.（US）
• Siemens Healthineers AG（Germany）
• Danaher（US）
• Canon Inc.（Minaris Medical America, Inc.）（Japan/US）
• Eurofins Scientific（Luxembourg）
• EUROIMMUN Medizinische Labordiagnostika AG（Revvity Inc.）（Germany/US）
• bioMerieux SA（France）
• Stallergenes Greer Ltd.（UK）
• HollisterStier Allergy（US）
• Omega Diagnostics Group PLC（UK）
• R-Biopharm AG（Germany）
• HYCOR Biomedical（US）
• Lincoln Diagnostics, Inc.（US）
• HOB Biotech Group Corp., Ltd.（China）
• Romer Labs Division Holding GmbH（Austria）
• AESKU.GROUP GmbH（Germany）
• Neogen Corporation（US）
• ALK-Abello A/S（Denmark）
• Abbott Laboratories（US）
• Phadia（part of Thermo Fisher Scientific）（Sweden/US）

結論和建議

Allergy Diagnostics Market size was valued at USD 4.8 billion in 2023 and is poised to grow from USD 5.33 billion in 2024 to USD 12.28 billion by 2032, growing at a CAGR of 11.0% during the forecast period (2025-2032).

The allergy diagnostics market is experiencing significant growth, driven by an increasing prevalence of allergies, advancements in diagnostic technologies, and heightened awareness of testing options. Conditions such as hay fever, asthma, and food allergies are rising due to environmental factors and lifestyle changes, stimulating the industry's expansion. Innovations in tools like skin prick tests and molecular diagnostics enhance testing efficiency and accuracy. However, the market faces challenges, including regulatory hurdles, high costs of advanced technologies, and a lack of standardization, which can impact reliability and accessibility for patients. Despite these obstacles, the market is set to grow substantially, fueled by emerging diagnostic methods, the integration of machine learning and AI, and increased investments in healthcare infrastructure.

Top-down and bottom-up approaches were used to estimate and validate the size of the Allergy Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Allergy Diagnostics Market Segments Analysis

Global Allergy Diagnostics Market is segmented by Product, Tests, Allergen, End User and region. Based on Product, the market is segmented into Assay Kits, Instruments, Services and Consumables. Based on Tests, the market is segmented into In-vivo Tests and In-vitro Tests. Based on Allergen, the market is segmented into Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens. Based on End User, the market is segmented into Diagnostic Laboratories, Hospital-Based Laboratories, Academic Research Institutes and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Allergy Diagnostics Market

The rising trend of personalized medicine is significantly influencing the allergy diagnostics market. There is a growing demand for allergy testing that provides detailed insights into individual sensitivities, facilitating more tailored treatment options. Ongoing research focused on identifying specific biomarkers linked to allergies enhances the ability to develop customized therapeutic strategies. This shift towards personalized approaches not only improves patient care but also contributes to the expansion of the allergy diagnostics industry, as healthcare providers seek tools that enable them to deliver more targeted and effective treatments based on individual patient profiles.

Restraints in the Allergy Diagnostics Market

The proliferation of home testing kits and DIY methods is posing a significant challenge to the growth of the allergy diagnostics market. While these home-based allergy tests provide convenience for patients, they often lack the accuracy and reliability of laboratory diagnostics. This shift in preference may lead to a decline in demand for professional testing services, adversely impacting market expansion. Additionally, the adoption of DIY methods and home remedies could further stagnate the allergy diagnostics industry as patients opt for less reliable alternatives over professional consultation and testing, ultimately undermining the effectiveness and revenue potential of established diagnostic facilities.

Market Trends of the Allergy Diagnostics Market

The Allergy Diagnostics market is witnessing a significant trend towards the adoption of molecular diagnostic techniques, such as allergen component testing and next-generation sequencing. These advanced methodologies facilitate precise identification of allergens at a molecular level, leading to more accurate diagnostics and the development of tailored treatment plans that cater to individual patient sensitivities. As a result, healthcare providers can deliver enhanced patient outcomes, fostering a shift towards personalized medicine in allergy management. The use of established molecular methods, including ELISA, PCR, and NHS, is expected to surge, further propelling market growth and innovation in allergy diagnostics.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis

Global Allergy Diagnostics Market Size by Product & Services & CAGR (2025-2032)

• Market Overview
• Assay Kits
• Instruments
• Services
• Consumables

Global Allergy Diagnostics Market Size by Tests & CAGR (2025-2032)

• Market Overview
• In-vivo Tests
• In-vitro Tests

Global Allergy Diagnostics Market Size by Allergen & CAGR (2025-2032)

• Market Overview
• Inhaled Allergens
• Food Allergens
• Drug Allergens
• Other Allergens

Global Allergy Diagnostics Market Size by End User & CAGR (2025-2032)

• Market Overview
• Diagnostic Laboratories
• Hospital-Based Laboratories
• Academic Research Institutes
• Other End Users

Global Allergy Diagnostics Market Size & CAGR (2025-2032)

• North America (Product & Services, Tests, Allergen, End User)
  • US
  • Canada
• Europe (Product & Services, Tests, Allergen, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Services, Tests, Allergen, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Services, Tests, Allergen, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Services, Tests, Allergen, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Inc. (Minaris Medical America, Inc.) (Japan/US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EUROIMMUN Medizinische Labordiagnostika AG (Revvity Inc.) (Germany/US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stallergenes Greer Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HollisterStier Allergy (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omega Diagnostics Group PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• R-Biopharm AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HYCOR Biomedical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lincoln Diagnostics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HOB Biotech Group Corp., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Romer Labs Division Holding GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AESKU.GROUP GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ALK-Abello A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phadia (part of Thermo Fisher Scientific) (Sweden/US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations